Here are 1-3 brief analogies for RCM Technologies (RCMT):

• Imagine a smaller, specialized version of Accenture, providing a mix of technology, engineering, and business solutions, alongside extensive healthcare staffing services.

• Think of a blend between AMN Healthcare (for its specialized medical staffing) and an engineering and IT consulting firm like Capgemini.

• Engineering Services: Provides a full spectrum of engineering support, including design, analysis, project management, and technical documentation for various industries.
• Healthcare Staffing and Recruitment: Offers temporary and permanent placement of healthcare professionals, therapists, nurses, and physicians across diverse healthcare settings.
• IT and Life Sciences Solutions: Delivers comprehensive information technology services, such as enterprise business solutions, application development, infrastructure management, and specialized life sciences technology support.

RCM Technologies (RCMT) primarily sells its business and technology solutions, as well as staffing services, to other companies and organizations.

Based on the provided company description, specific major customer company names are not disclosed. However, RCM Technologies serves a diverse client base across numerous industries and sectors. Its major customers can be categorized by the industries and types of organizations it serves, which include:

• Aerospace and Defense industry
• Energy industry
• Financial Services industry
• Health Care industry
• Life Sciences industry
• Manufacturing and Distribution industry
• Technology industry
• Educational Institutions
• The Public Sector

Bradley S. Vizi, Executive Chairman & President

Bradley S. Vizi is a primary force in the governance and strategy of RCM Technologies, Inc., holding a substantial individual ownership stake in the company. He is the largest individual shareholder, owning 19% of the outstanding shares as of July 3, 2025. Mr. Vizi has emphasized the importance of share count reductions to improve shareholder returns and has overseen significant share buybacks. He has been actively involved in the company's leadership for an extended period.

Kevin D. Miller, Chief Financial Officer, Treasurer, Principal Accounting Officer and Secretary

Kevin D. Miller has served as the Chief Financial Officer, Secretary, and Treasurer at RCM Technologies Inc. since October 2008. Prior to this role, he was the Senior Vice President of RCM from July 1997 to September 2008. Mr. Miller also worked as an Associate in the Corporate Finance Department of Legg Mason Wood Walker, Incorporated from 1996 to 1997, and as a Business Consultant for the Wharton Small Business Development Center from 1995 to 1996. His earlier experience includes serving as an Associate in both the audit and corporate finance groups at Ernst & Young LLP.

Michael Saks, Division President, Health Care Services

Michael Saks oversees the Health Care Services segment, which generates the majority of RCM Technologies' revenue.

Tina Ciocca, Executive Vice President, Aerospace & Defense

Tina Ciocca holds the position of Executive Vice President, Aerospace & Defense at RCM Technologies.

William Gargano, Group Senior Vice President, Life Sciences & IT Services

William Gargano serves as the Group Senior Vice President for the Life Sciences & IT Services segment of RCM Technologies.

Here are the key risks to the business of RCM Technologies (RCMT):

1. Economic Factors, Market Demand Fluctuations, and Wage Inflation: RCM Technologies is significantly exposed to the broader economic environment, which can impact client capital expenditure budgets and demand for its services. Persistent inflation and high interest rates have been noted to pressure capital expenditure for IT and Engineering clients, leading to a slowdown in discretionary IT/Consulting and Life Sciences & Data Solutions. The company's gross profit in the Life Sciences & Data Solutions segment declined by 4.2% year-over-year in Q3 2025. Furthermore, the Specialty Health Care segment experienced an 11% decline in revenue due to reduced demand for travel nurse services and challenging comparisons to prior COVID-related revenues. Wage inflation, particularly in the nursing sector, also squeezes profit margins. Operational inefficiencies, reflected in lower utilization rates, have also contributed to a decrease in gross margin.

2. Cybersecurity Threats and Data Privacy: As a provider of technology solutions, RCM Technologies faces ongoing risks from cybersecurity threats. If realized, these threats could materially affect the company's operations, business strategy, results of operations, or financial condition. The company's 10-K filings explicitly mention risks related to cybersecurity, data privacy, data center capacity, and telecommunication links.

3. Dependence on a Concentrated Group of Customers: A significant portion of RCM Technologies' condensed consolidated revenues is contributed by a concentrated group of customers. This customer concentration poses a risk, as the loss of one or more major clients or a significant reduction in business from them could materially and adversely affect the company's financial performance and results of operations.

The emergence of advanced AI and machine learning-driven staffing platforms and recruitment technologies poses a clear threat to RCM Technologies' Specialty Health Care segment. These platforms automate candidate sourcing, matching, and screening, potentially offering faster, more cost-effective, and efficient recruitment solutions that could disintermediate traditional human-centric staffing agencies.

Additionally, the rapid advancements in hyper-automation, AI-powered development tools (e.g., low-code/no-code platforms, generative AI for code), and increasingly integrated cloud-native services from major providers threaten to commoditize or significantly alter the demand for traditional enterprise business solutions, application services, and infrastructure solutions within RCM Technologies' Life Sciences and Information Technology segment. This could reduce the need for human-intensive IT services that RCMT currently provides, shifting value towards highly specialized consulting or platform-specific integration.

RCM Technologies operates within three main segments, each addressing significant market opportunities:

• Engineering: The global engineering services market was valued at approximately USD 2.34 trillion in 2025 and is projected to grow to USD 5.37 trillion by 2034, exhibiting a compound annual growth rate (CAGR) of 10.60% from 2026 to 2034. For the U.S. specifically, the market size was estimated at USD 0.45 trillion in 2026.
• Specialty Health Care: The U.S. healthcare staffing market, which includes long-term and short-term staffing, executive search, and placement services, was estimated at USD 45.48 billion in 2025. It is projected to reach USD 89.71 billion by 2033, growing at a CAGR of 6.98% from 2026 to 2033.
• Life Sciences and Information Technology: This segment encompasses two primary areas:
  • Life Sciences IT/Software: The global life sciences IT market was estimated at USD 25.45 billion in 2024 and is expected to reach USD 69.01 billion in 2034, expanding at a CAGR of 10.49% over the forecast period of 2025-2034. In North America, the market was valued at US$ 35.42 billion in 2024 and is anticipated to reach approximately US$ 110.75 billion by 2034, expanding at a CAGR of 12.08% from 2025 to 2034.
  • IT Consulting Services: The global IT consulting services market was valued at approximately USD 78.03 billion in 2024 and is projected to reach USD 129.15 billion by 2034, growing at a CAGR of roughly 6.50% between 2025 and 2034.

RCM Technologies (RCMT) is expected to drive future revenue growth over the next 2-3 years through several key initiatives across its segments:

1. Expansion of Specialty Health Care Services: The company anticipates continued growth in its Specialty Health Care segment, particularly in school-related services. This growth is projected to be around 20% for the school year spanning July 2024 to June 2025, supported by the acquisition of over 20 new school contracts. Additionally, RCM Technologies is broadening its K-12 behavioral health services and Health Information Management (HIM) offerings, and it possesses a robust pipeline of international nurses expected to accelerate growth in both healthcare and education sectors.
2. Growth in Engineering Services from Infrastructure and Aerospace: RCM Technologies is well-positioned for growth in its Engineering segment, leveraging significant trends such as grid modernization and data center expansion. The company has secured multi-year preferred partner agreements for comprehensive engineering services and has a record engineering backlog of over $70 million for 2026, a substantial increase from the prior year. Its Aerospace Group also demonstrated strong performance, exceeding its Q1 2025 business plan objectives by over 20% in revenue.
3. Advancements and New Client Acquisition in Life Sciences and Information Technology: The Life Sciences and Information Technology segment is expected to grow through high-value managed service offerings, particularly in commercialization, data integrity, and quality improvement programs. RCM Technologies is actively securing new clients in the pharmaceutical and biotech sectors and is investing in AI-driven equipment qualification and data integrity solutions to streamline compliance and enhance audit readiness. The broader Revenue Cycle Management (RCM) market, relevant to their IT services, is also projected to grow significantly, driven by AI adoption.

Share Repurchases

• RCM Technologies has consistently repurchased shares over the last 3-5 years, leading to a significant reduction in common shares outstanding. The number of shares outstanding decreased from 10.29 million at the end of 2021 to 7.41 million at the end of 2025.
• In the last year, the number of shares outstanding decreased by 4.33%.

Share Issuance

• There have been no significant share issuances over the last 3-5 years, with the overall trend showing a decrease in outstanding shares.

Capital Expenditures

• Capital expenditures were $3 million in 2023 and $3 million in 2024.
• In the last 12 months, capital expenditures totaled -$2.38 million.
• Capital expenditures are projected to be $2 million annually from 2025 to 2029, representing approximately 1% of revenue.